STAT

NOVEMBER 15, 2024

As the saying goes, you are what you eat. And, unfortunately, the food we eat is only solidifying America’s tragic title: We have the lowest life expectancy among large high-income countries. The U.S. Food and Drug Administration is taking a number of steps to help people in the U.S. build healthy diets — including with respect to ultra-processed foods — and the food industry and research community should, too.

349

349

BioPharma Dive

NOVEMBER 15, 2024

At an event hosted by BioPharma Dive, drugmaker executives and investors discussed the importance of focus, smart spending and maintaining lines of sight to the clinic.

126

126

STAT

NOVEMBER 15, 2024

Michelle Monje-Deisseroth says she first treated patients with “the worst imaginable childhood brain tumor” as a medical student about 20 years ago. Diffuse intrinsic pontine gliomas, or DIPG, shackle themselves so insidiously around a young person’s brainstem that no chemo or scalpel can wrest them out. Most children didn’t survive a year.

356

356

PharmaVoice

NOVEMBER 15, 2024

How Novavax and others have restructured and trudged forward after their COVID-era high.

130

130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

NOVEMBER 15, 2024

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. The schedule at my YMCA recently changed so that my swim workout time now coincides with an Aqua Zumba class. There’s nothing more motivating for a workout than a bunch of ladies chanting/Zumba-ing to the Wobble next to you, and that’s the energy I hope you take into this weekend.

250

250

Pharmaceutical Technology

NOVEMBER 15, 2024

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Sanofi’s Sarclisa combined with Velcade, plus Revlimid, plus dexamethasone (VRd) for treating newly diagnosed multiple myeloma (MM).

96

96

The Pharmacist

NOVEMBER 15, 2024

Government advisers have greatly narrowed the groups who they recommend for Covid vaccine eligibility on the NHS next autumn. The Joint Committee on Vaccination and Immunisation (JCVI) said both the spring and autumn Covid vaccine campaigns in 2025 should be restricted to the over-75s, residents of a care home for older adults and those six […] The post Covid vaccine eligibility should shrink next year as disease becomes endemic, says JCVI appeared first on The Pharmacist.

Vaccines 98

Vaccines 98

STAT

NOVEMBER 15, 2024

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

198

198

Express Pharma

NOVEMBER 15, 2024

Granules India announced that it has received the Golden Peacock Award for Sustainability. This award was presented at the Institute of Directors’ Annual Global Convention on Corporate Governance and Sustainability being held in London, UK. This recognition follows a competitive selection process with 499 applicants and a three-tier assessment, establishing Granules as a leader in sustainable practices in India.

98

98

STAT

NOVEMBER 15, 2024

The death  of Rick Slayman,  the first man to receive a kidney transplant from a genetically engineered pig , was caused by an “unexpected cardiac event,” and there was no sign his body was rejecting the organ, his transplant surgeon said Wednesday. The disclosure, six months after the 62-year-old Weymouth, Mass. resident died, was the first public explanation of Slayman’s cause of death and the most detailed confirmation that Slayman’s new kidney was still

Hospitals 162

Hospitals 162

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

The Pharmacist

NOVEMBER 15, 2024

Claire Burrows, partner at Brabners LLP and Thorrun Govind, solicitor at Brabners LLP, pharmacist and TV health expert, provide further insight into ongoing MHRA work on legislation covering medical devices. If you missed their last piece click here. The explosion of innovation in health technology in recent years has the potential to bring transformative approaches […] The post Post-market surveillance requirements for medical devices: Implications appeared first on The Pharmacist.

86

86

Express Pharma

NOVEMBER 15, 2024

In the last few years, we have witnessed the pharmaceutical industry in its most intense form. With the onset of the COVID-19 pandemic, they have spared no effort in providing crucial vaccinations to protect the world. Today, they are utilising advanced technologies to speed up the creation of therapies and treatments to eliminate life-threatening diseases.

Pharmaceutical Companies 89

Pharmaceutical Companies Pharmaceutical Companies Vaccines 89

Drug Channels

NOVEMBER 15, 2024

Today’s guest post comes from Kala Bala, SVP, Enterprise Access & Data Expertise, MMIT, a Norstella company and Dinesh Kabaleeswaran, SVP, Advisory Services at MMIT, a Norstella company. The authors outline the challenges that manufacturers face when integrating internal and external datasets to build market access and commercialization strategies.

79

79

The Pharmacist

NOVEMBER 15, 2024

A delegation of community pharmacists is set to meet with the UK Government's minister for Northern Ireland, Fleur Anderson, next month to discuss rising financial challenges facing the sector. The group will be led by Ulster Unionist Party peer Lord Rogan who said local pharmacies had been dispensing at a loss for 'far too long', […] The post Northern Ireland's pharmacists to meet with minister after vote to reduce services appeared first on The Pharmacist.

81

81

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

BioPharma Dive

NOVEMBER 15, 2024

Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke with BioPharma Dive about how the company came together.

67

67

Express Pharma

NOVEMBER 15, 2024

Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in website. It meets the healthcare needs of over 1.4 billion people domestically while providing affordable medicines to over 200 countries, significantly contributing to global public health.

Packaging 74

Packaging Generic Medicine Pharmaceutical Manufacturing Vaccines 74

BioPharma Dive

NOVEMBER 15, 2024

The San Diego biotech made an unsolicited bid to buy Evotec for 2 billion euros. Elsewhere, Bluebird recorded its first Lyfgenia revenue and Leerink built up its M&A team.

60

60

GMPSOP

NOVEMBER 15, 2024

Stability testing overview for Pharmaceutical products Pharmaceuticals quality assurance & validation procedures GMPSOP %title% Prev PREVIOUS POST Pharmaceutical products must maintain quality, safety, purity and efficacy throughout their specified shelf-life conditions up to their nominated expiration date. Stability testing ensures that the manufactured products remain safe, pure, and effective throughout their shelf life if they are kept in specified packaging and under environmental cond

Packaging 59

Packaging Dosage Documentation Labelling 59

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharma Marketing Network

NOVEMBER 15, 2024

In the world of pharmaceutical marketing, social media marketing strategies are more than a trend; they’re a necessity. But with strict regulations and evolving consumer expectations, how do pharma brands navigate the digital landscape effectively? The answer lies in a mix of proven strategies designed for this unique sector. Table of Contents Sr# Headings 1 Know Your Audience and Their Needs 2 Leverage Branded and Unbranded Content 3 Engage Responsibly and Transparently 4 Utilize Influenc

Diabetes 52

Diabetes 52

Compounding Pharmacy of America

NOVEMBER 15, 2024

Melatonin is a natural hormone produced by our bodies. When taken as a supplement, the hormone can deliver important health benefits, like sleep support. The post Melatonin Uses and Benefits appeared first on The Compounding Pharmacy of America.

Compounding Pharmacies 52

Compounding Pharmacies Compounding Immunization Immunity 52

Pharma Marketing Network

NOVEMBER 15, 2024

In today’s digital-first world, Pay Per Click (PPC) advertising has become an essential strategy for pharma marketing executives. Imagine having a tool that allows you to target specific audiences actively searching for healthcare solutions, like branded medications or treatment options. PPC does just that. But how does it work, and how can you make the most of it in the competitive pharmaceutical industry?

Diabetes 52

Diabetes 52

PharmExec

NOVEMBER 15, 2024

A look at one biotech’s mission to map the immune system using artificial intelligence—and how its growth as a Big Pharma partner could help unlock the potential of next-generation cancer treatments.

Immunity 52

Immunity Immunization 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Marketing Network

NOVEMBER 15, 2024

The digital landscape has transformed how pharmaceutical brands reach healthcare professionals (HCPs) and patients. Digital advertising is no longer just a nice addition; it’s a must-have for every successful pharma marketing strategy. But how do you make your campaigns stand out in such a highly regulated and competitive industry? Let’s explore some proven strategies that will help you master digital advertising and drive significant results.

52

52

PharmExec

NOVEMBER 15, 2024

Developments in the world of artificial intelligence continue to accelerate at a rapid pace. Our November issue of Pharmaceutical Executive explores a few of those that are starting to deliver measurable gains for the industry.

52

52

European Pharmaceutical Review

NOVEMBER 15, 2024

BeiGene Ltd is planning to change its company’s name to BeOne Medicines Ltd. The oncology organisation stated that its new name and logo illustrates its “focus on coming together against cancer”. BeiGene – a new vision “Be” represents being disease free, with “One” underlining [BeiGene’s] shared mission to overcome [cancer]” Within the new logo design, “Be” represents being disease free, with “One” underlining the company’s shared mission to overcome the disease, according to B

Labelling 52

Labelling 52

Pharmaceutical Technology

NOVEMBER 15, 2024

The US Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals’ Danziten (nilotinib), the first and only nilotinib formulation that does not require mealtime restrictions, to treat chronic myeloid leukaemia (CML).

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

NOVEMBER 15, 2024

Explore valuable tips and strategies to enhance clinical trials by prioritising and improving the overall patient experience. Learn how to optimise patient recruitment, retention, and satisfaction through effective communication and personalised support.

Communication 52

Communication 52

Pharmaceutical Business Review

NOVEMBER 15, 2024

The FDA has set a target action date of 18 April 2025 for its decision. If approved, Dupixent is expected to become the first targeted CSU therapy in ten years. Sanofi and Regeneron resubmitted the sBLA based on findings from the LIBERTY-CUPID Phase III clinical programme. The LIBERTY-CUPID Phase III studies comprise Study A, Study B, and Study C. Study A and Study C focused on CSU patients inadequately controlled by antihistamines, while Study B included those unresponsive to both antihistamine

52

52

Pharmaceutical Commerce

NOVEMBER 15, 2024

In the first part of this roundtable discussion, a panel of subject matter experts introduce themselves, while discussing why the pharma supply chain sees value in this technology and why its use has fluctuated over the past decade.

52

52

Pharmaceutical Technology

NOVEMBER 15, 2024

MSD has secured an exclusive worldwide license from LaNova Medicines for developing, manufacturing, and commercialising the latter’s new investigational programmed cell death 1 (PD-1)/vascular endothelial growth factor (VEGF) bispecific antibody, LM-299.

52

52

PharmaTech

NOVEMBER 15, 2024

Executives at Avantor talk about the future of the biopharmaceutical industry and the anticipated impact that a wave of next-generation biotherapeutics will bring.

52

52